Evidence map›Paper›PMID 39468223›Full record

ArticleOncogene2025

Hypoxia-dependent recruitment of error-prone DNA polymerases to genome replication.

Ran Yehuda, Ido Dromi, Yishai Levin, Thomas Carell, Nicholas Geacintov, Zvi Livneh

Abstract read
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Role ofMicroorganisms · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ran YehudaDept. of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Ido DromiDept. of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Yishai LevinThe de Botton Institute for Protein Profiling of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Thomas CarellCenter for Integrated Protein Science at the Department of Chemistry, Ludwig-Maximilians- Universität, München, Butenandtstrasse 5-13, 81377, München, Germany.ORCID 0000-0001-7898-2831
Nicholas GeacintovChemistry Department, New York University, New York, NY, USA.
Zvi LivnehDept. of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel. zvi.livneh@weizmann.ac.il.ORCID 0000-0003-1677-7677

Funding

Flight Attendant Medical Research Institute (Flight Attendant Medical Research Institute, Inc.) #032001Israel Science Foundation (ISF) #1129/18
6 · The paper itself

Abstract

Hypoxia is common in tumors and is associated with cancer progression and drug resistance, driven, at least in part, by genetic instability. Little is known on how hypoxia affects Translesion DNA Synthesis (TLS), in which error-prone DNA polymerases bypass lesions, thereby maintaining DNA continuity at the price of increased mutations. Here we show that under acute hypoxia, PCNA monoubiquitination, a key step in TLS, and expression of error-prone DNA polymerases increased under regulation of the HIF1α transcription factor. Knocking-down expression of DNA polymerase η, or using PCNA ubiquitination-resistant cells, inhibited genomic DNA replication specifically under hypoxia, and iPOND analysis revealed massive recruitment of TLS DNA polymerases to nascent DNA under hypoxia, uncovering a dramatic involvement of error-prone DNA polymerases in genomic replication. Of note, expression of TLS-polymerases correlates with VEGFA (primary HIF1α target) in a database of renal cell carcinoma, a cancer which accumulates HIF1α. Our results suggest that the tumor microenvironment can lead the cell to forgo, to some extent, the fast and accurate canonical DNA polymerases, for the more flexible and robust, but low-fidelity TLS DNA polymerases. This might endow cancer cells with resilience to overcome replication stress, and mutability to escape the immune system and chemotherapeutic drugs.

Indexed as

DNA-Directed DNA PolymeraseDNA ReplicationHypoxia-Inducible Factor 1, alpha SubunitProliferating Cell Nuclear AntigenUbiquitinationCarcinoma, Renal CellCell HypoxiaCell Line, TumorHumansKidney NeoplasmsVascular Endothelial Growth Factor AY-Family DNA PolymerasesDNA-Directed DNA PolymeraseHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitPCNA protein, humanProliferating Cell Nuclear AntigenRad30 proteinVascular Endothelial Growth Factor AVEGFA protein, humanY-Family DNA Polymerases

Identifiers

PMID39468223
PMCPMC11700837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.